Interethnic genetic differences in the prevalence of polymorphisms affecting drug-metabolizing enzymes, drug transporters, and receptors are well documented and must be considered within the perspective of individualized pharmacotherapy. Pharmacologically relevant genetic polymorphisms are rarely present or absent exclusively in one of the three major continental populations (African, Asian and European) that have been more extensively investigated. Possible examples are the CYP2C9*2 allele, which has not been reported in Asians, and both TPMT*2 and *3A, which appear to be absent in Africans. In most cases of documented interethnic pharmacogenomic differences, it is the allelic frequency of polymorphic loci which vary across continental populations; the mean variation, however, remains substantially smaller than the variation between individuals comprising these populations. This is not surprising, since only B10% of the total human genetic diversity stems from continental rather than individual differences. Irrespective of whether human 'races' are social constructs without biological meaning, there is overwhelming evidence for genetic admixture in people from different ancestries in most, if not all populations.In the American continent, the autochtonous Amerindians, and people of European and African origin, contributed in different degrees and in a genderspecific manner to the formation of the tri-hybrid population of the present time. In the United States, the average European admixture in African-Americans has been estimated as B19-26%, whereas the percentage of non-European alleles in Euro-Americans is less than 5%.1 Brazil, the largest country in South America and the fifth largest in the world, is inhabited by a highly heterogeneous population of 180 million people. Estimates based on matrilineal ancestry (mitochondrial DNA (mtDNA) haplotypes) in Brazilians self-identified as white indicate similar contributions (30-40%) of Amerindian, African and European females, although significant regional differences were noted, with higher Amerindian contribution in the North region and predominance of European ancestry in the South. In contrast, less than 5% of the patrilineal ancestry (Y-chromosome) in white Brazilians was non-European. Conversely, in self-identified black Brazilians, European ancestry is higher in the Y chromosome as compared to the mtDNA. [2][3][4][5] These observations are consistent with the evidence of asymmetrical mating in relation to sex and ethnicity, which occurred in the formation of the Brazilian population. The extensive admixture of Brazilians makes also ethnic classifications, based on continental origin, parental background or physical appearance rather relative. Furthermore, race identification is not a static characteristic-a person who is 'black' in the United States may be 'white' in Brazil, where no racial descent rule is operational, and it is possible for two siblings differing in 'color' to be included in diverse racial or ethnic categories.Interethnic admixture introduc...